메뉴 건너뛰기




Volumn 295, Issue 21, 2006, Pages 2492-2502

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; UNCLASSIFIED DRUG;

EID: 33744960226     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.21.2492     Document Type: Article
Times cited : (3164)

References (49)
  • 3
    • 2642575788 scopus 로고    scopus 로고
    • Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma
    • Porter PL, Lund MJ, Lin MG, et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer. 2004;100:2533-2542.
    • (2004) Cancer , vol.100 , pp. 2533-2542
    • Porter, P.L.1    Lund, M.J.2    Lin, M.G.3
  • 4
    • 84942005124 scopus 로고
    • Racial differences in survival from breast cancer: Results of the National Cancer Institute Black/White Cancer Survival Study
    • Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer: results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994;272:947-954.
    • (1994) JAMA , vol.272 , pp. 947-954
    • Eley, J.W.1    Hill, H.A.2    Chen, V.W.3
  • 5
    • 0037163481 scopus 로고    scopus 로고
    • Cancer survival among US whites and minorities: A SEER (Surveillance, Epidemiology, and End Results) Program population-based study
    • Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162:1985-1993.
    • (2002) Arch Intern Med , vol.162 , pp. 1985-1993
    • Clegg, L.X.1    Li, F.P.2    Hankey, B.F.3    Chu, K.4    Edwards, B.K.5
  • 6
    • 0037029024 scopus 로고    scopus 로고
    • Racial and ethnic disparities in the receipt of cancer treatment
    • Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94:334-357.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 334-357
    • Shavers, V.L.1    Brown, M.L.2
  • 7
    • 0037961266 scopus 로고    scopus 로고
    • Racial differences in mammographic breast density
    • del Carmen MG, Hughes KS, Halpern E, et al. Racial differences in mammographic breast density. Cancer. 2003;98:590-596.
    • (2003) Cancer , vol.98 , pp. 590-596
    • Del Carmen, M.G.1    Hughes, K.S.2    Halpern, E.3
  • 8
    • 0037346703 scopus 로고    scopus 로고
    • Racial differences in genetic factors associated with breast cancer
    • Ademuyiwa FO, Olopade OI. Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev. 2003;22:47-53.
    • (2003) Cancer Metastasis Rev , vol.22 , pp. 47-53
    • Ademuyiwa, F.O.1    Olopade, O.I.2
  • 9
    • 0037108283 scopus 로고    scopus 로고
    • Racial differences in treatment and survival from early-stage breast carcinoma
    • Joslyn SA. Racial differences in treatment and survival from early-stage breast carcinoma. Cancer. 2002;95:1759-1766.
    • (2002) Cancer , vol.95 , pp. 1759-1766
    • Joslyn, S.A.1
  • 10
    • 13844287355 scopus 로고    scopus 로고
    • Assessing genetic contributions to phenotypic differences among "racial" and "ethnic" groups
    • Mountain JL, Risch N. Assessing genetic contributions to phenotypic differences among "racial" and "ethnic" groups. Nat Genet. 2004;36(11 suppl):S48-S53.
    • (2004) Nat Genet , vol.36 , Issue.11 SUPPL.
    • Mountain, J.L.1    Risch, N.2
  • 11
    • 0035799778 scopus 로고    scopus 로고
    • Racial profiling in medical research
    • Schwartz RS. Racial profiling in medical research. N Engl J Med. 2001;344:1392-1393.
    • (2001) N Engl J Med , vol.344 , pp. 1392-1393
    • Schwartz, R.S.1
  • 12
    • 14344260474 scopus 로고    scopus 로고
    • Will tomorrow's medicines work for everyone?
    • Tate SK, Goldstein DB. Will tomorrow's medicines work for everyone? Nat Genet. 2004;36(11 suppl):S34-S42.
    • (2004) Nat Genet , vol.36 , Issue.11 SUPPL.
    • Tate, S.K.1    Goldstein, D.B.2
  • 13
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.
    • (2000) Nature , vol.406 , pp. 747-752
    • Perou, C.M.1    Sorlie, T.2    Eisen, M.B.3
  • 14
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-10874.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 10869-10874
    • Sorlie, T.1    Perou, C.M.2    Tibshirani, R.3
  • 15
    • 0037478605 scopus 로고    scopus 로고
    • Repeated observation of breast tumor subtypes in independent gene expression data sets
    • Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418-8423.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 8418-8423
    • Sorlie, T.1    Tibshirani, R.2    Parker, J.3
  • 16
    • 0042838307 scopus 로고    scopus 로고
    • Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    • Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003;100:10393-10398.
    • (2003) Proc Natl Acad Sci U S a , vol.100 , pp. 10393-10398
    • Sotiriou, C.1    Neo, S.Y.2    McShane, L.M.3
  • 17
    • 4143150688 scopus 로고    scopus 로고
    • Immunohistochemical and clinical characterization of the basallike subtype of invasive breast carcinoma
    • Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basallike subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367-5374.
    • (2004) Clin Cancer Res , vol.10 , pp. 5367-5374
    • Nielsen, T.O.1    Hsu, F.D.2    Jensen, K.3
  • 18
    • 0035834759 scopus 로고    scopus 로고
    • RERG is a novel RAS-related, estrogen-regulated and growth-inhibitory gene in breast cancer
    • Finlin BS, Gau CL, Murphy GA, et al. RERG is a novel RAS-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem. 2001;276:42259-42267.
    • (2001) J Biol Chem , vol.276 , pp. 42259-42267
    • Finlin, B.S.1    Gau, C.L.2    Murphy, G.A.3
  • 19
    • 7044240645 scopus 로고    scopus 로고
    • Mutation of GATA3 in human breast tumors
    • Usary J, Llaca V, Karaca G, et al. Mutation of GATA3 in human breast tumors. Oncogene. 2004;23:7669-7678.
    • (2004) Oncogene , vol.23 , pp. 7669-7678
    • Usary, J.1    Llaca, V.2    Karaca, G.3
  • 20
    • 0035931947 scopus 로고    scopus 로고
    • Gene-expression profiles in hereditary breast cancer
    • Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539-548.
    • (2001) N Engl J Med , vol.344 , pp. 539-548
    • Hedenfalk, I.1    Duggan, D.2    Chen, Y.3
  • 21
    • 18244409687 scopus 로고    scopus 로고
    • Gene expression profiling predicts clinical outcome of breast cancer
    • van 't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530-536.
    • (2002) Nature , vol.415 , pp. 530-536
    • Van 't Veer, L.J.1    Dai, H.2    Van De Vijver, M.J.3
  • 22
    • 0029052963 scopus 로고
    • The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology
    • Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51-60.
    • (1995) Breast Cancer Res Treat , vol.35 , pp. 51-60
    • Newman, B.1    Moorman, P.G.2    Millikan, R.3
  • 23
    • 0033037235 scopus 로고    scopus 로고
    • Participation rates in a case-control study: The impact of age, race, and race of interviewer
    • Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol. 1999;9:188-195.
    • (1999) Ann Epidemiol , vol.9 , pp. 188-195
    • Moorman, P.G.1    Newman, B.2    Millikan, R.C.3    Tse, C.K.4    Sandler, D.P.5
  • 24
    • 0031903725 scopus 로고    scopus 로고
    • Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk
    • Millikan RC, Pittman GS, Newman B, et al. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998;7:371-378.
    • (1998) Cancer Epidemiol Biomarkers Prev , vol.7 , pp. 371-378
    • Millikan, R.C.1    Pittman, G.S.2    Newman, B.3
  • 25
    • 0031948563 scopus 로고    scopus 로고
    • Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: Major importance of the mitotic count as a component of both grading systems
    • Genestie C, Zafrani B, Asselain B, et al. Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems. Anticancer Res. 1998;18(1B):571-576.
    • (1998) Anticancer Res , vol.18 , Issue.1 B , pp. 571-576
    • Genestie, C.1    Zafrani, B.2    Asselain, B.3
  • 26
    • 0034174298 scopus 로고    scopus 로고
    • Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status
    • Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000;151:703-714.
    • (2000) Am J Epidemiol , vol.151 , pp. 703-714
    • Huang, W.Y.1    Newman, B.2    Millikan, R.C.3    Schell, M.J.4    Hulka, B.S.5    Moorman, P.G.6
  • 27
    • 0017360990 scopus 로고
    • The measurement of observer agreement for categorical data
    • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
    • (1977) Biometrics , vol.33 , pp. 159-174
    • Landis, J.R.1    Koch, G.G.2
  • 28
    • 0037899640 scopus 로고    scopus 로고
    • HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites
    • Millikan R, Eaton A, Worley K, et al. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Res Treat. 2003;79:355-364.
    • (2003) Breast Cancer Res Treat , vol.79 , pp. 355-364
    • Millikan, R.1    Eaton, A.2    Worley, K.3
  • 29
    • 0036899446 scopus 로고    scopus 로고
    • Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome
    • van de Rijn M, Perou CM, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 2002;161:1991-1996.
    • (2002) Am J Pathol , vol.161 , pp. 1991-1996
    • Van De Rijn, M.1    Perou, C.M.2    Tibshirani, R.3
  • 30
    • 0036531921 scopus 로고    scopus 로고
    • Prevalence and spectrum of p53 mutations associated with smoking in breast cancer
    • Conway K, Edmiston SN, Cui L, et al. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res. 2002;62:1987-1995.
    • (2002) Cancer Res , vol.62 , pp. 1987-1995
    • Conway, K.1    Edmiston, S.N.2    Cui, L.3
  • 31
    • 0032565070 scopus 로고    scopus 로고
    • Frequency of breast cancer attributable to BRCA1 in a population-based series of American women
    • Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King MC. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA. 1998;279:915-921.
    • (1998) JAMA , vol.279 , pp. 915-921
    • Newman, B.1    Mu, H.2    Butler, L.M.3    Millikan, R.C.4    Moorman, P.G.5    King, M.C.6
  • 32
    • 0028061542 scopus 로고
    • Test of the National Death Index and Equifax Nationwide Death Search
    • Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140:1016-1019.
    • (1994) Am J Epidemiol , vol.140 , pp. 1016-1019
    • Rich-Edwards, J.W.1    Corsano, K.A.2    Stampfer, M.J.3
  • 35
    • 33646842210 scopus 로고    scopus 로고
    • Survival probabilities (the Kaplan-Meier method)
    • Bland JM, Altman DG. Survival probabilities (the Kaplan-Meier method). BMJ. 1998;317:1572.
    • (1998) BMJ , vol.317 , pp. 1572
    • Bland, J.M.1    Altman, D.G.2
  • 36
    • 2342659010 scopus 로고    scopus 로고
    • The logrank test
    • Bland JM, Altman DG. The logrank test. BMJ. 2004;328:1073.
    • (2004) BMJ , vol.328 , pp. 1073
    • Bland, J.M.1    Altman, D.G.2
  • 38
    • 0025215247 scopus 로고
    • Power and sample size calculations: A review and computer program
    • Dupont WD, Plummer WD. Power and sample size calculations: a review and computer program. Control Clin Trials. 1990;11:116-128.
    • (1990) Control Clin Trials , vol.11 , pp. 116-128
    • Dupont, W.D.1    Plummer, W.D.2
  • 39
    • 7844247959 scopus 로고    scopus 로고
    • p53 Mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours
    • Crook T, Brooks LA, Crossland S, et al. p53 Mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. Oncogene. 1998;17:1681-1689.
    • (1998) Oncogene , vol.17 , pp. 1681-1689
    • Crook, T.1    Brooks, L.A.2    Crossland, S.3
  • 40
    • 10744223743 scopus 로고    scopus 로고
    • The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
    • Foulkes WD, Brunet JS, Stefansson IM, et al. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular- proliferation+) phenotype of BRCA1-related breast cancer. Cancer Res. 2004;64:830-835.
    • (2004) Cancer Res , vol.64 , pp. 830-835
    • Foulkes, W.D.1    Brunet, J.S.2    Stefansson, I.M.3
  • 41
    • 0141429017 scopus 로고    scopus 로고
    • Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
    • Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95:1482-1485.
    • (2003) J Natl Cancer Inst , vol.95 , pp. 1482-1485
    • Foulkes, W.D.1    Stefansson, I.M.2    Chappuis, P.O.3
  • 42
    • 0035963498 scopus 로고    scopus 로고
    • Gene-expression profiles in hereditary breast cancer
    • Olopade OI, Grushko T. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:2028-2029.
    • (2001) N Engl J Med , vol.344 , pp. 2028-2029
    • Olopade, O.I.1    Grushko, T.2
  • 43
    • 0036494110 scopus 로고    scopus 로고
    • Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers
    • Grushko TA, Blackwood MA, Schumm PL, et al. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Res. 2002;62:1481-1488.
    • (2002) Cancer Res , vol.62 , pp. 1481-1488
    • Grushko, T.A.1    Blackwood, M.A.2    Schumm, P.L.3
  • 44
    • 0031408437 scopus 로고    scopus 로고
    • Germline BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer
    • Foulkes WD, Wong N, Brunet JS, et al. Germline BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res. 1997;3:2465-2469.
    • (1997) Clin Cancer Res , vol.3 , pp. 2465-2469
    • Foulkes, W.D.1    Wong, N.2    Brunet, J.S.3
  • 45
    • 0034671417 scopus 로고    scopus 로고
    • Familial invasive breast cancers: Worse outcome related to BRCA1 mutations
    • Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, et al. Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol. 2000;18:4053-4059.
    • (2000) J Clin Oncol , vol.18 , pp. 4053-4059
    • Stoppa-Lyonnet, D.1    Ansquer, Y.2    Dreyfus, H.3
  • 46
    • 4143089281 scopus 로고    scopus 로고
    • Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations
    • Yu K, Lee CH, Tan PH, Tan P. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res. 2004;10:5508-5517.
    • (2004) Clin Cancer Res , vol.10 , pp. 5508-5517
    • Yu, K.1    Lee, C.H.2    Tan, P.H.3    Tan, P.4
  • 47
    • 33744949538 scopus 로고    scopus 로고
    • "Intrinsic gene expression" subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestry
    • Paper presented June New Orleans, La.
    • Olopade OI, Ikpatt FO, Dignam JJ, et al. "Intrinsic gene expression" subtypes correlated with grade and morphometric parameters reveal a high proportion of aggressive basal-like tumors among black women of African ancestry. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2004; New Orleans, La.
    • (2004) American Society of Clinical Oncology Annual Meeting
    • Olopade, O.I.1    Ikpatt, F.O.2    Dignam, J.J.3
  • 48
    • 0035985177 scopus 로고    scopus 로고
    • Identification of genes periodically expressed in the human cell cycle and their expression in tumors
    • Whitfield ML, Sherlock G, Saldanha AJ, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell. 2002;13:1977-2000.
    • (2002) Mol Biol Cell , vol.13 , pp. 1977-2000
    • Whitfield, M.L.1    Sherlock, G.2    Saldanha, A.J.3
  • 49
    • 18244422222 scopus 로고    scopus 로고
    • HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
    • Press MF, Bernstein L, Thomas PA, et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. J Clin Oncol. 1997;15:2894-2904.
    • (1997) J Clin Oncol , vol.15 , pp. 2894-2904
    • Press, M.F.1    Bernstein, L.2    Thomas, P.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.